Getting Human Papillomavirus Vaccination Back on Track: Protecting Our National Investment in Human Papillomavirus Vaccination in the COVID-19 Era

[1]  S. Stokley,et al.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[2]  M. Drainoni,et al.  Provider Experience Recommending HPV Vaccination Before Age 11 Years. , 2019, The Journal of pediatrics.

[3]  E. Meites,et al.  HPV Vaccine Delivery Practices by Primary Care Physicians , 2019, Pediatrics.

[4]  N. Basta,et al.  National Trends in Parental Human Papillomavirus Vaccination Intentions and Reasons for Hesitancy, 2010–2015 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Meena E. Sheley,et al.  Simple and Elaborated Clinician Reminder Prompts for Human Papillomavirus Vaccination: A Randomized Clinical Trial. , 2018, Academic pediatrics.

[6]  Alexander J. Rothman,et al.  Increasing Vaccination: Putting Psychological Science Into Action , 2017, Psychological science in the public interest : a journal of the American Psychological Society.

[7]  A. McRee,et al.  Provider communication about HPV vaccination: A systematic review , 2016, Human vaccines & immunotherapeutics.

[8]  B. Rimer,et al.  Summer Peaks in Uptake of Human Papillomavirus and Other Adolescent Vaccines in the United States , 2015, Cancer Epidemiology, Biomarkers and Prevention.

[9]  N. V. A. Committee.  Assessing the State of Vaccine Confidence in the United States: Recommendations from the National Vaccine Advisory Committee , 2015 .

[10]  B. Gellin,et al.  Assessing the State of Vaccine Confidence in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015 [corrected]. , 2015, Public health reports.